Molecular Pathway Activation Markers Predicting Efficacy of Trastuzumab Therapy for HER2-positive Breast Cancer

Name: Molecular Pathway Activation Markers Predicting Efficacy of Trastuzumab Therapy for HER2-positive Breast Cancer
Published: 2017
License: Public Domain

OmicsWay Corp. · 2017

ClinicalTrials.gov · Datasets · License: Public Domain · 2017

Open Source ↗

biomarkers breastcancer egfr ngs rnaseq targetedtherapy

her2-positive breast cancer, breast cancer, epidermal growth factor receptor, her2, egfr, biomarkers, targeted therapy, ngs, rnaseq, mrna, transcriptome analysis, signaling pathway

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 801333
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.